AI offers significant benefits to science. Researchers have used specialised AI models to solve scientific problems for many ...

Any use of AI – or even less sophisticated methods of standardization ... Demand for apheresis for this population has grown recently in no small part due to the recent approval of two gene therapies, ...

With the rapid advancement of artificial intelligence (AI) technology, it has significantly impacted various fields within ...

The startup will also use its generative AI technology to optimize manufacturing of the gene therapy, leveraging data that MeiraGTx has amassed over the course of nearly a decade developing its ...

GeneDx will present the AI-powered decision support tool at ACMG, in a session: Multiscore, a Gene Ranker Powered by Artificial Intelligence and Real-World Clinical Data, Shows High Sensitivity in ...

company specialising in multimodal generative AI models, to advance its Parkinson’s disease gene therapy programme. Hologen has committed up to $430m in funding to support the development and ...

Artificial intelligence company Hologen AI has committed up to $430 million as part of a multifaceted agreement to help take MeiraGTx’s Parkinson’s disease gene therapy all the way to market.

“The first wave of CRISPR therapies has focused on a small number of monogenic diseases caused by single-gene mutations. By bringing together AWS’s powerful cloud computing and AI solutions ...

The new AI model leverages hypergraphs to quickly and accurately identify therapeutic gene targets for diseases BUSAN, South Korea, March 6, 2025 /PRNewswire/ -- Identifying therapeutic gene ...